We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.2M
AUM Growth
+$10.1M
(+13%)
Cap. Flow
+$4.72M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
114
New
6
Increased
84
Reduced
17
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$801K |
| 2 |
InMode
INMD
|
+$412K |
| 3 |
Abbott
ABT
|
+$402K |
| 4 |
Robert Half
RHI
|
+$266K |
| 5 |
Comcast
CMCSA
|
+$266K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$749K |
| 2 |
Corpay
CPAY
|
+$635K |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$622K |
| 4 |
AMN Healthcare
AMN
|
+$407K |
| 5 |
KeyCorp
KEY
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.82% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 10.23% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.54T
| $5.36M | 6.08% |
32,501
+1,232
| +4% | +$182K |
|
2
Microsoft
MSFT
$3.45T
| $5.03M | 5.7% |
17,430
+886
| +5% | +$226K |
|
3
Amazon
AMZN
$2.92T
| $2.15M | 2.44% |
20,864
+1,222
| +6% | +$118K |
|
4
Alphabet (Google) Class C
GOOG
$4.36T
| $2.05M | 2.33% |
19,728
+173
| +0.9% | +$16.7K |
|
5
NVIDIA
NVDA
$4.86T
| $1.76M | 2% |
63,470
-5,840
| -8% | -$126K |
|
6
JPMorgan Chase
JPM
$935B
| $1.76M | 1.99% |
13,489
+752
| +6% | +$103K |
|
7
Eli Lilly
LLY
$1.02T
| $1.75M | 1.98% |
5,082
+393
| +8% | +$133K |
|
|
8
Comcast
CMCSA
$85B
| $1.59M | 1.81% |
42,067
+7,028
| +20% | +$266K |
|
9
RTX Corp
RTX
$290B
| $1.52M | 1.73% |
15,540
+443
| +3% | +$43.6K |
|
10
NextEra Energy
NEE
$181B
| $1.51M | 1.71% |
19,598
+655
| +3% | +$50.4K |
|
11
PepsiCo
PEP
$190B
| $1.46M | 1.65% |
7,998
-6
| -0.1% | -$1.05K |
|
|
12
Abbott
ABT
$183B
| $1.42M | 1.61% |
13,997
+3,809
| +37% | +$402K |
|
13
ExxonMobil
XOM
$644B
| $1.41M | 1.6% |
12,827
+522
| +4% | +$57.7K |
|
14
Walmart Inc
WMT
$885B
| $1.4M | 1.58% |
28,395
+1,065
| +4% | +$50.5K |
|
15
Thermo Fisher Scientific
TMO
$213B
| $1.37M | 1.56% |
2,381
+175
| +8% | +$98.6K |
|
16
Verizon
VZ
$195B
| $1.37M | 1.55% |
35,250
+1,371
| +4% | +$54.1K |
|
17
Mastercard
MA
$502B
| $1.34M | 1.53% |
3,702
+108
| +3% | +$39.2K |
|
18
O'Reilly Automotive
ORLY
$72.9B
| $1.32M | 1.5% |
23,385
+1,545
| +7% | +$84.7K |
|
19
Microchip Technology
MCHP
$40.3B
| $1.23M | 1.39% |
14,653
-446
| -3% | -$35.6K |
|
20
Costco
COST
$422B
| $1.21M | 1.38% |
2,443
+65
| +3% | +$31.9K |
|
21
Booking.com
BKNG
$149B
| $1.14M | 1.29% |
10,700
+100
| +0.9% | +$9.73K |
|
22
Ametek
AME
$55.4B
| $1.1M | 1.25% |
7,559
+586
| +8% | +$83.3K |
|
23
Waste Management
WM
$90.6B
| $1.09M | 1.24% |
6,681
+319
| +5% | +$48.9K |
|
24
Chubb
CB
$135B
| $1.07M | 1.21% |
5,492
+566
| +11% | +$119K |
|
25
Humana
HUM
$43.7B
| $1.04M | 1.18% |
2,141
+134
| +7% | +$66.2K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, First National Advisers held 114 positions worth $88.2M, up 13% from $78.1M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
First National Advisers deployed $4.72M of net new capital in Q1 2023, opening 6 new positions and adding to 84 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 5,416 shares worth $793K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $749K trimmed.
- First National Advisers's largest Q1 2023 buy was Jazz Pharmaceuticals: 5,416 shares worth $793K.
- First National Advisers added most to Abbott in Q1 2023, an estimated $402K increase.
- First National Advisers's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $749K.
- First National Advisers fully exited Corpay in Q1 2023, selling an estimated $635K.
- First National Advisers's ten largest holdings make up 28% of its $88.2M portfolio in Q1 2023.
- First National Advisers opened 6 new positions and closed 4 in Q1 2023.
- First National Advisers's portfolio value rose 13% quarter-over-quarter to $88.2M.
Based on First National Advisers's 13F filing for Q1 2023, filed 10 May 2023.